Difference between revisions of "Pilgramm1"

(Imported from Wikispaces)
 
 
Line 1: Line 1:
−
'''<span style="font-family: &#39;Times New Roman&#39;,&#39;serif&#39;; font-size: 16px;">Hyperbaric oxygen following acute acoustic trauma may be associated with improvement of tinnitus and more rapid return of hearing.</span>'''
 
  
−
<span style="border-color: windowtext; border-style: solid; border-width: 1.5pt; display: block; padding: 1pt 4pt;">
+
<span style="line-height:normal">'''<span style="font-size:18.0pt"><span style="font-family:" times="" new="" roman",serif"="">Hyperbaric oxygen following acute acoustic trauma may be associated with improvement of tinnitus and more rapid return of hearing.</span></span>'''</span>
−
<span style="padding-bottom: 0cm; padding-left: 0cm; padding-right: 0cm; padding-top: 0cm;">'''<span style="font-family: &#39;Times New Roman&#39;,&#39;serif&#39;; font-size: 16px;">Clinical Bottom Line:</span>'''
 
−
<span style="font-family: &#39;Times New Roman&#39;,&#39;serif&#39;; font-size: 16px;">1. Some evidence that hyperbaric oxygen is associated with improvement in tinnitus following acute acoustic trauma.
 
−
2. Some evidence that hearing recovery may also be improved to some degree.
 
−
3. Hyperbaric oxygen appears to reduce the incidence of later deterioration in hearing and/or tinnitus.</span></span>
 
−
</span>
 
−
**<span style="font-family: &#39;Times New Roman&#39;,&#39;serif&#39;; font-size: 16px;">Appraised by:</span>'''<span style="font-family: &#39;Times New Roman&#39;,&#39;serif&#39;; font-size: 16px;"> Mike Bennett, Dept of Diving and Hyperbaric Medicine, Prince of Wales Hospital, Sydney; Sunday, 28 March 1999</span>
 
  
−
**<span style="font-family: &#39;Times New Roman&#39;,&#39;serif&#39;; font-size: 16px;">Clinical Scenario:</span>'''<span style="font-family: &#39;Times New Roman&#39;,&#39;serif&#39;; font-size: 16px;"> A patient presenting with acoustic trauma resulting in hearing loss.</span>
+
<span style="line-height:normal">'''<span style="font-size:14.0pt"><span style="font-family:" times="" new="" roman",serif"="">Clinical Bottom Line:</span></span>'''</span>
−
**<span style="font-family: &#39;Times New Roman&#39;,&#39;serif&#39;; font-size: 16px;">Three-part Question:</span>'''<span style="font-family: &#39;Times New Roman&#39;,&#39;serif&#39;; font-size: 16px;"> In patients with acute hearing loss and tinnitus following acoustic trauma, does the administration of hyperbaric oxygen, in addition to a standard sorbitol and dextran infusion, result in any improvement in outcome?</span>
 
−
**<span style="font-family: &#39;Times New Roman&#39;,&#39;serif&#39;; font-size: 16px;">Search Terms:</span>'''<span style="font-family: &#39;Times New Roman&#39;,&#39;serif&#39;; font-size: 16px;"> Acoustic trauma, deafness, tinnitus.</span>
 
  
−
**<span style="font-family: &#39;Times New Roman&#39;,&#39;serif&#39;; font-size: 16px;">The Study:</span>'''
+
#<span style="line-height:normal"><span style="font-size:14.0pt"><span style="font-family:" times="" new="" roman",serif"="">Some evidence that hyperbaric oxygen improves tinnitus following acoustic trauma.</span></span></span>  
−
<span style="font-family: &#39;Times New Roman&#39;,&#39;serif&#39;; font-size: 16px;">Non-blinded concealed randomised controlled trial with intention-to-treat.</span>
+
#<span style="line-height:normal"><span style="font-size:14.0pt"><span style="font-family:" times="" new="" roman",serif"="">Some evidence that there may be some return of hearing</span></span></span>
−
<span style="font-family: &#39;Times New Roman&#39;,&#39;serif&#39;; font-size: 16px;">Young male patients with acute acoustic trauma within the last 48 hours and associated with greater than 40dB hearing loss which has not improved more than 20dB in the first 24 hours.</span>
+
#<span style="line-height:normal"><span style="font-size:14.0pt"><span style="font-family:" times="" new="" roman",serif"="">Hyperbaric oxygen may reduce the incidence of later deterioration in tinnitus or hearing</span></span></span>  
−
<span style="font-family: &#39;Times New Roman&#39;,&#39;serif&#39;; font-size: 16px;">Control group (N = 59; 59 analysed): Standard IV protocol of 25g sorbitol and 50g dextran daily for 14 days. Half of this group also received 24mg betahistidine daily.</span>
 
−
<span style="font-family: &#39;Times New Roman&#39;,&#39;serif&#39;; font-size: 16px;">Experimental group (N = 61; 61 analysed): Same two IV protocol groups plus 100% oxygen at 2.8bar (?ATA) for 60 minutes daily for 10 days.</span>
 
  
−
**<span style="font-family: &#39;Times New Roman&#39;,&#39;serif&#39;; font-size: 16px;">The Evidence:</span>'''
+
----
−
{|
+
 
−
| <span style'''"display: block; text-align: center;"><span style'''"display: block; text-align: center;">'''<span style'''"font-family: &#39;Times New Roman&#39;,&#39;serif&#39;;">Outcome</span>'''</span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; text-align: center;">'''<span style'''"font-family: &#39;Times New Roman&#39;,&#39;serif&#39;;">Time to Outcome</span>'''</span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; text-align: center;">'''<span style'''"font-family: &#39;Times New Roman&#39;,&#39;serif&#39;;">Air group</span>'''</span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; text-align: center;">'''<span style'''"font-family: &#39;Times New Roman&#39;,&#39;serif&#39;;">HBO group</span>'''</span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; text-align: center;">'''<span style'''"font-family: &#39;Times New Roman&#39;,&#39;serif&#39;;">Relative risk reduction</span>'''</span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; text-align: center;">'''<span style'''"font-family: &#39;Times New Roman&#39;,&#39;serif&#39;;">Absolute risk reduction</span>'''</span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; text-align: center;">'''<span style="font-family: &#39;Times New Roman&#39;,&#39;serif&#39;;">NNT</span>'''</span></span>  
+
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Citations:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">1. Pilgramm M, Schumann K. Hyperbaric oxygen therapy for acute acoustic trauma. Archives of Otolaryngology 1985; 241:247-254.</span></span></span>
 +
 
 +
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Clinical Scenario:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">A patient presenting with acoustic trauma resulting in hearing loss.</span></span></span>
 +
 
 +
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Three-part Question:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">In patients with acute hearing loss and tinnitus following acoustic trauma, does the administration of hyperbaric oxygen, in addition to a standard sorbitol and dextran infusion, result in any improvement in outcome?</span></span></span>
 +
 
 +
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Search Terms:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Acoustic trauma, deafness, tinnitus</span></span></span>
 +
 
 +
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">The Study:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Non-blinded randomised controlled trial with intention-to-treat. Young male patients with acute acoustic trauma within the last 48 hours and associated with greater than 40dB hearing loss which has not improved more than 20dB in the first 24 hours.</span></span></span>
 +
 
 +
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Control group (N = 59; 59 analysed):</span></span>'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Standard IV protocol of 25g sorbitol and 50g dextran daily for 14 days. Half of this group also received 24mg betahistidine daily.</span></span></span>
 +
 
 +
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Experimental group (N = 61; 61 analysed):</span></span>'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Same two IV protocol groups plus 100% oxygen at 2.8 bar (?ATA) for 60 minutes daily for 10 days.</span></span></span>
 +
 
 +
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">The Evidence:</span></span>'''</span>
 +
 
 +
{| class="Table" style="border:solid windowtext 1.0pt"
 
|-
 
|-
−
| <span style'''"display: block; text-align: center;"><span style'''"display: block; text-align: center;">'''<span style'''"font-family: &#39;Times New Roman&#39;,&#39;serif&#39;;">Deterioration after discharge</span>'''</span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: Times New Roman,serif; text-align: center;">14 days</span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: Times New Roman,serif; text-align: center;">0.271</span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: Times New Roman,serif; text-align: center;">0.049</span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: Times New Roman,serif; text-align: center;">82%</span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: Times New Roman,serif; text-align: center;">0.222</span></span> || <span style'''"display: block; text-align: center;"><span style="display: block; font-family: Times New Roman,serif; text-align: center;">5</span></span>  
+
| style="border:solid windowtext 1.0pt" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Outcome</span></span>'''</span></p>  
 +
| style="width:50.1pt; border:solid windowtext 1.0pt" width="69" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Time to Outcome</span></span>'''</span></p>
 +
| style="width:41.05pt; border:solid windowtext 1.0pt" width="57" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Air group</span></span>'''</span></p>
 +
| style="width:48.15pt; border:solid windowtext 1.0pt" width="66" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">HBO group</span></span>'''</span></p>
 +
| style="width:69.35pt; border:solid windowtext 1.0pt" width="94" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Relative risk reduction</span></span>'''</span></p>
 +
| style="width:76.45pt; border:solid windowtext 1.0pt" width="104" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Absolute risk reduction</span></span>'''</span></p>
 +
| style="width:51.9pt; border:solid windowtext 1.0pt" width="72" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">NNT</span></span>'''</span></p>  
 
|-
 
|-
−
| <span style'''"display: block; text-align: center;"><span style'''"display: block; text-align: center;">'''<span style'''"font-family: &#39;Times New Roman&#39;,&#39;serif&#39;;">95% CI:</span>'''</span></span> ||  ||  ||  || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: Times New Roman,serif; text-align: center;">36% to 100%</span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: Times New Roman,serif; text-align: center;">0.096 to 0.348</span></span> || <span style'''"display: block; text-align: center;"><span style="display: block; font-family: Times New Roman,serif; text-align: center;">3 to 10</span></span>  
+
| rowspan="2" style="border:solid windowtext 1.0pt" |
 +
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Deterioration after discharge</span></span>'''</span>
 +
 
 +
| style="width:50.1pt; border:solid windowtext 1.0pt" width="69" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">14 days</span></span></span></p>
 +
| style="width:41.05pt; border:solid windowtext 1.0pt" width="57" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">0.27</span></span></span></p>
 +
| style="width:48.15pt; border:solid windowtext 1.0pt" width="66" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">0.05</span></span></span></p>
 +
| style="width:69.35pt; border:solid windowtext 1.0pt" width="94" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">82%</span></span></span></p>
 +
| style="width:76.45pt; border:solid windowtext 1.0pt" width="104" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">0.22</span></span></span></p>
 +
| style="width:51.9pt; border:solid windowtext 1.0pt" width="72" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">5</span></span></span></p>  
 
|-
 
|-
 +
| style="width:50.1pt; border:solid windowtext 1.0pt; padding:.75pt .75pt .75pt .75pt" width="69" | &nbsp;
 +
| style="width:41.05pt; border:solid windowtext 1.0pt; padding:.75pt .75pt .75pt .75pt" width="57" | &nbsp;
 +
| style="width:48.15pt; border:solid windowtext 1.0pt" width="66" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">95% CI:</span></span></span></p>
 +
| style="width:69.35pt; border:solid windowtext 1.0pt" width="94" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">36% to 100%</span></span></span></p>
 +
| style="width:76.45pt; border:solid windowtext 1.0pt" width="104" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">0.1 to 0.35</span></span></span></p>
 +
| style="width:51.9pt; border:solid windowtext 1.0pt" width="72" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">3 to 10</span></span></span></p>
 
|}
 
|}
  
−
{|
+
&nbsp;
−
| <span style'''"line-height: normal; margin-bottom: 0pt;">'''Non-event outcomes'''</span> || <span style'''"display: block; line-height: normal; margin-bottom: 0pt; text-align: center;"><span style'''"display: block; text-align: center;">'''Time to outcome'''</span></span> || <span style'''"display: block; line-height: normal; margin-bottom: 0pt; text-align: center;"><span style'''"display: block; text-align: center;">'''rTPA group'''</span></span> || <span style'''"display: block; line-height: normal; margin-bottom: 0pt; text-align: center;"><span style'''"display: block; text-align: center;">'''HBO and rTPA group'''</span></span> || <span style'''"display: block; line-height: normal; margin-bottom: 0pt; text-align: center;"><span style="display: block; text-align: center;">'''P-value'''</span></span>
+
<div align="center">
 +
{| class="Table" style="border:solid windowtext 1.0pt"
 
|-
 
|-
−
| <span style'''"line-height: normal; margin-bottom: 0pt;">'''Mean 6kHz hearing loss(dB)'''</span> || <span style'''"display: block; line-height: normal; margin-bottom: 0pt; text-align: center;"><span style'''"display: block; text-align: center;">42 days</span></span> || <span style'''"display: block; line-height: normal; margin-bottom: 0pt; text-align: center;"><span style'''"display: block; text-align: center;">15</span></span> || <span style'''"display: block; line-height: normal; margin-bottom: 0pt; text-align: center;"><span style'''"display: block; text-align: center;">2</span></span> || <span style'''"display: block; line-height: normal; margin-bottom: 0pt; text-align: center;"><span style="display: block; text-align: center;">Not given</span></span>  
+
| style="width:109.0pt; border:solid windowtext 1.0pt" width="148" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Non-event outcomes</span></span>'''</span></p>
 +
| style="width:56.75pt; border:solid windowtext 1.0pt" width="78" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Time to outcome</span></span>'''</span></p>
 +
| style="width:57.15pt; border:solid windowtext 1.0pt" width="78" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">rTPA group</span></span>'''</span></p>
 +
| style="width:71.3pt; border:solid windowtext 1.0pt" width="97" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">HBO and rTPA group</span></span>'''</span></p>
 +
| style="width:68.75pt; border:solid windowtext 1.0pt" width="94" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Difference</span></span>'''</span></p>
 +
| style="width:77.35pt; border:solid windowtext 1.0pt" width="106" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">P-value</span></span>'''</span></p>  
 
|-
 
|-
−
| <span style'''"line-height: normal; margin-bottom: 0pt;">'''Hearing improvement(%)'''</span> || <span style'''"display: block; line-height: normal; margin-bottom: 0pt; text-align: center;"><span style'''"display: block; text-align: center;">7 days</span></span> || <span style'''"display: block; line-height: normal; margin-bottom: 0pt; text-align: center;"><span style'''"display: block; text-align: center;">52.7</span></span> || <span style'''"display: block; line-height: normal; margin-bottom: 0pt; text-align: center;"><span style'''"display: block; text-align: center;">75.8</span></span> || <span style'''"display: block; line-height: normal; margin-bottom: 0pt; text-align: center;"><span style="display: block; text-align: center;">Not given</span></span>  
+
| style="width:109.0pt; border:solid windowtext 1.0pt" width="148" |
 +
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Mean 6kHz hearing loss(dB)</span></span>'''</span>
 +
 
 +
| style="width:56.75pt; border:solid windowtext 1.0pt" width="78" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">42 days</span></span></span></p>
 +
| style="width:57.15pt; border:solid windowtext 1.0pt" width="78" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">15</span></span></span></p>
 +
| style="width:71.3pt; border:solid windowtext 1.0pt" width="97" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">2</span></span></span></p>
 +
| style="width:68.75pt; border:solid windowtext 1.0pt" width="94" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">13</span></span></span></p>
 +
| style="width:77.35pt; border:solid windowtext 1.0pt" width="106" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Not given</span></span></span></p>  
 
|-
 
|-
−
| <span style'''"line-height: normal; margin-bottom: 0pt;">'''Hearing improvement(%)'''</span> || <span style'''"display: block; line-height: normal; margin-bottom: 0pt; text-align: center;"><span style'''"display: block; text-align: center;">42 days</span></span> || <span style'''"display: block; line-height: normal; margin-bottom: 0pt; text-align: center;"><span style'''"display: block; text-align: center;">76.2</span></span> || <span style'''"display: block; line-height: normal; margin-bottom: 0pt; text-align: center;"><span style'''"display: block; text-align: center;">87.7</span></span> || <span style'''"display: block; line-height: normal; margin-bottom: 0pt; text-align: center;"><span style="display: block; text-align: center;">Not given</span></span>  
+
| style="width:109.0pt; border:solid windowtext 1.0pt" width="148" |
 +
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Hearing improvement(%)</span></span>'''</span>
 +
 
 +
| style="width:56.75pt; border:solid windowtext 1.0pt" width="78" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">7 days</span></span></span></p>
 +
| style="width:57.15pt; border:solid windowtext 1.0pt" width="78" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">52.7</span></span></span></p>
 +
| style="width:71.3pt; border:solid windowtext 1.0pt" width="97" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">75.8</span></span></span></p>
 +
| style="width:68.75pt; border:solid windowtext 1.0pt" width="94" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">23.1</span></span></span></p>
 +
| style="width:77.35pt; border:solid windowtext 1.0pt" width="106" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Not given</span></span></span></p>  
 
|-
 
|-
−
| '''<span style'''"font-family: &#39;Times New Roman&#39;,Times,serif; font-size: 15px;">Mean improvement in tinnitus(dB) </span>''' || <span style'''"display: block; line-height: normal; margin-bottom: 0pt; text-align: center;"><span style'''"display: block; text-align: center;">42 days</span></span> || <span style'''"display: block; line-height: normal; margin-bottom: 0pt; text-align: center;"><span style'''"display: block; text-align: center;">0</span></span> || <span style'''"display: block; line-height: normal; margin-bottom: 0pt; text-align: center;"><span style'''"display: block; text-align: center;">6.5</span></span> || <span style'''"display: block; line-height: normal; margin-bottom: 0pt; text-align: center;"><span style="display: block; text-align: center;">Not given</span></span>  
+
| style="width:109.0pt; border:solid windowtext 1.0pt" width="148" |
 +
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Hearing improvement(%)</span></span>'''</span>
 +
 
 +
| style="width:56.75pt; border:solid windowtext 1.0pt" width="78" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">42 days</span></span></span></p>
 +
| style="width:57.15pt; border:solid windowtext 1.0pt" width="78" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">76.2</span></span></span></p>
 +
| style="width:71.3pt; border:solid windowtext 1.0pt" width="97" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">87.7</span></span></span></p>
 +
| style="width:68.75pt; border:solid windowtext 1.0pt" width="94" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">11.5</span></span></span></p>
 +
| style="width:77.35pt; border:solid windowtext 1.0pt" width="106" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Not given</span></span></span></p>  
 
|-
 
|-
 +
| style="width:109.0pt; border:solid windowtext 1.0pt" width="148" |
 +
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Mean improvement in tinnitus(dB)</span></span>'''</span>
 +
 +
| style="width:56.75pt; border:solid windowtext 1.0pt" width="78" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">42 days</span></span></span></p>
 +
| style="width:57.15pt; border:solid windowtext 1.0pt" width="78" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">0</span></span></span></p>
 +
| style="width:71.3pt; border:solid windowtext 1.0pt" width="97" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">6.5</span></span></span></p>
 +
| style="width:68.75pt; border:solid windowtext 1.0pt" width="94" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">6.5</span></span></span></p>
 +
| style="width:77.35pt; border:solid windowtext 1.0pt" width="106" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Not given</span></span></span></p>
 
|}
 
|}
 +
</div>
 +
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Comments:</span></span>'''</span>
 +
 +
<span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">1. Very difficult study to read as results are presented in a confusing manner.</span></span></span>
 +
 +
<span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">2. No significance testing for hearing improvement, tinnitus, rate of recovery or late deterioration make interpretation difficult. The non-event results above have been calculated by this reviewer</span></span></span>
 +
 +
<span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">3. No definition for 'deterioration' given.</span></span></span>
  
−
**<span style="font-family: &#39;Times New Roman&#39;,&#39;serif&#39;; font-size: 16px;">Comments:</span>'''
+
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Appraised by:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Mike Bennett, Dept of Diving and Hyperbaric Medicine, Prince of Wales Hospital, Sydney; Sunday, 28 March 1999</span></span></span>
−
<span style="font-family: &#39;Times New Roman&#39;,&#39;serif&#39;; font-size: 16px;">1. Very difficult study to read as results are presented in a confusing manner.</span>
 
−
<span style="font-family: &#39;Times New Roman&#39;,&#39;serif&#39;; font-size: 16px;">2. No significance testing for hearing improvement, tinnitus, rate of recovery or late deterioration make interpretation difficult. The non-event results above have been calculated by this reviewer</span>
 
−
<span style="font-family: &#39;Times New Roman&#39;,&#39;serif&#39;; font-size: 16px;">3. No definition for 'deterioration' given.</span>
 
  
−
**<span style="font-family: &#39;Times New Roman&#39;,&#39;serif&#39;; font-size: 16px;">Expiry date:</span>'''<span style="font-family: &#39;Times New Roman&#39;,&#39;serif&#39;; font-size: 16px;"> June 2020</span>
+
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Expiry date:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">June 2020</span></span></span>
−
**<span style="font-family: &#39;Times New Roman&#39;,&#39;serif&#39;; font-size: 16px;">References: </span>'''<span style="font-family: &#39;Times New Roman&#39;,&#39;serif&#39;; font-size: 16px;">1. Pilgramm M, Schumann K. Hyperbaric oxygen therapy for acute acoustic trauma. Archives of Otolaryngology 1985; 241:247-254.</span>
 
  
−
[[File:sumhorsa.gif|center]]
+
[[File:Sumhorsa.gif|center|Sumhorsa.gif]]
  
−
<span style="display: block; text-align: center;"><span style="font-size: 230%;">[[Audiovestibular | BACK]]</span></span>
+
<span style="display: block; text-align: center;"><span style="font-size: 230%;">[[Audiovestibular|BACK]]</span></span>

Latest revision as of 21:00, 27 September 2021

Hyperbaric oxygen following acute acoustic trauma may be associated with improvement of tinnitus and more rapid return of hearing.

Clinical Bottom Line:

  1. Some evidence that hyperbaric oxygen improves tinnitus following acoustic trauma.
  2. Some evidence that there may be some return of hearing
  3. Hyperbaric oxygen may reduce the incidence of later deterioration in tinnitus or hearing

Citations:1. Pilgramm M, Schumann K. Hyperbaric oxygen therapy for acute acoustic trauma. Archives of Otolaryngology 1985; 241:247-254.

Clinical Scenario:A patient presenting with acoustic trauma resulting in hearing loss.

Three-part Question:In patients with acute hearing loss and tinnitus following acoustic trauma, does the administration of hyperbaric oxygen, in addition to a standard sorbitol and dextran infusion, result in any improvement in outcome?

Search Terms:Acoustic trauma, deafness, tinnitus

The Study:Non-blinded randomised controlled trial with intention-to-treat. Young male patients with acute acoustic trauma within the last 48 hours and associated with greater than 40dB hearing loss which has not improved more than 20dB in the first 24 hours.

Control group (N = 59; 59 analysed):Standard IV protocol of 25g sorbitol and 50g dextran daily for 14 days. Half of this group also received 24mg betahistidine daily.

Experimental group (N = 61; 61 analysed):Same two IV protocol groups plus 100% oxygen at 2.8 bar (?ATA) for 60 minutes daily for 10 days.

The Evidence:

Outcome

Time to Outcome

Air group

HBO group

Relative risk reduction

Absolute risk reduction

NNT

Deterioration after discharge

14 days

0.27

0.05

82%

0.22

5

   

95% CI:

36% to 100%

0.1 to 0.35

3 to 10

 

Non-event outcomes

Time to outcome

rTPA group

HBO and rTPA group

Difference

P-value

Mean 6kHz hearing loss(dB)

42 days

15

2

13

Not given

Hearing improvement(%)

7 days

52.7

75.8

23.1

Not given

Hearing improvement(%)

42 days

76.2

87.7

11.5

Not given

Mean improvement in tinnitus(dB)

42 days

0

6.5

6.5

Not given

Comments:

1. Very difficult study to read as results are presented in a confusing manner.

2. No significance testing for hearing improvement, tinnitus, rate of recovery or late deterioration make interpretation difficult. The non-event results above have been calculated by this reviewer

3. No definition for 'deterioration' given.

Appraised by:Mike Bennett, Dept of Diving and Hyperbaric Medicine, Prince of Wales Hospital, Sydney; Sunday, 28 March 1999

Expiry date:June 2020

Sumhorsa.gif

BACK